Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by elgin1on May 19, 2020 9:29am

110 Views

Post# 31045152

RE:Results !

Basically they are saying they have a cure for Hemophilia . They take the Hemophilia patients endothelial cell, isolate gene defect for Hemophilia , Favtor viii , reinsert the fixed gene into thepouch,pouch produces factor viii, and cures Hemophilia. Quite an achievement.

This indication is is important for valuation for Sernova in the longterm. Let’s see when they release data for additional patients.

Bullboard Posts

Invest wiser with BMO's InvestorLine Platform features